Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications

This publication has 30 references indexed in Scilit:

• Long-term tacrine treatment in patients with Alzheimer's disease
  The Lancet, 1996
• Double-Blind, Placebo-Controlled Study of Metrifonate, an Acetylcholinesterase Inhibitor, for Alzheimer Disease
  Alzheimer Disease & Associated Disorders, 1996
• Long-term effects of tacrine in alzheimer's disease: An open study
  International Journal of Geriatric Psychiatry, 1994
• Long-term use of tacrine
  The Lancet, 1994
• Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models
  Neurobiology of Aging, 1990
• Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial
  Drug Development Research, 1990
• Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
  New England Journal of Medicine, 1986
• The effects of physostigmine on acetylcholinesterase activity of CSF, plasma and brain. A comparison of intravenous and intra ventricular administration in beagle dogs
  Neuropharmacology, 1986
• Inhibition of Cholinesterases by Tetrahydroaminacrin.
  Acta Chemica Scandinavica, 1961
• THE PHARMACOLOGY OF SOME NEW ANTI‐CHOLINESTERASES
  Immunology & Cell Biology, 1953